Polaryx Therapeutics, Inc <PLYX.O>: Raymond James initiates coverage with strong buy rating; price target $6
PLYX•Related News
Aeternum Health acquires option to buy 51% stake in American Renaissance Minerals
AETN•
Traders add to bets on September Fed rate hold
TLT•
Assurant Inc <AIZ.N>: UBS Raises Target Price to $331 From $274
AIZ•
MongoDB partners with Voyage AI to power automated embeddings on Atlas
MDB•
HCA’s Sarah Cannon Research Institute partners with Merck to expand access to oncology clinical trials in US communities
HCA•